Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing; Graduate Institute of Health-Industry Technology, Research Center for Food and Cosmetic Safety, and Research Center for Chinese Herbal Medicine, College of Human Ecology, Chang Gung University of Science and Technology, Taoyuan City; Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung.
Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing.
Biochem Pharmacol. 2017 Sep 1;139:94-104. doi: 10.1016/j.bcp.2017.06.123. Epub 2017 Jun 19.
A long history of use and extensive documentation of the clinical practices of traditional Chinese medicine resulted in a considerable number of classical preparations, which are still widely used. This heritage of our ancestors provides a unique resource for drug discovery. Already, a number of important drugs have been developed from traditional medicines, which in fact form the core of Western pharmacotherapy. Therefore, this article discusses the differences in drug development between traditional medicine and Western medicine. Moreover, the article uses the discovery of artemisinin as an example that illustrates the "bedside-bench-bedside" approach to drug discovery to explain that the middle way for drug development is to take advantage of the best features of these two distinct systems and compensate for certain weaknesses in each. This article also summarizes evidence-based traditional medicines and discusses quality control and quality assessment, the crucial steps in botanical drug development. Herbgenomics may provide effective tools to clarify the molecular mechanism of traditional medicines in the botanical drug development. The totality-of-the-evidence approach used by the U.S. Food and Drug Administration for botanical products provides the directions on how to perform quality control from the field throughout the entire production process.
长期以来,传统中医药的使用和广泛的临床实践记录促成了大量经典制剂的产生,这些制剂至今仍被广泛应用。我们祖先的这一遗产为药物发现提供了独特的资源。事实上,已经有许多重要的药物是从传统药物中开发出来的,它们构成了西方药物治疗的核心。因此,本文讨论了传统医学和西方医学在药物开发方面的差异。此外,本文还以青蒿素的发现为例,说明了药物发现的“床边-实验台-床边”方法,阐明了药物开发的中间道路是利用这两个截然不同的系统的最佳特点,并弥补每个系统的某些弱点。本文还总结了基于证据的传统药物,并讨论了质量控制和质量评估,这是植物药开发的关键步骤。草药基因组学可能为阐明植物药开发中传统药物的分子机制提供有效的工具。美国食品和药物管理局对植物药产品使用的全证据方法为如何从整个生产过程的田间开始进行质量控制提供了方向。